Global Neuropathic Pain Market Research Report Forecast to 2023

Array
(
    [id] => 1333380
    [discount] => PDF-18-ENTERPRISE WIDE LICENCE-20------
    [isbn] => 
    [title] => Global Neuropathic Pain Market Research Report Forecast to 2023
    [upcommingtext] => 
    [seo_url] => global-neuropathic-pain-market-research-report-forecast-to-2023
    [shortdesc] => 
    [meta_title] => Global Neuropathic Pain Market Research Report Forecast to 2023
    [keyword] => Global Neuropathic Pain Market Research Report Forecast to 2023
    [description] => Global Neuropathic Pain Market Research Report, by Type (Peripheral Neuropathy, Entrapment Neuropathy, and Others), by Indication (Diabetic Neuropathy, Spinal Stenosis), by Diagnosis (Imaging, Blood Tests), by Treatment (Medication, Multimodal Therapy),
    [curr] => USD
    [category] => 1200
    [publisher] => 182
    [published_date] => 2019-03-25
    [country] => 230
    [author_name] => 
    [page_num] => 224
    [abstract] => Global Neuropathic Pain Market Research Report, by Type (Peripheral Neuropathy, Entrapment Neuropathy, and Others), by Indication (Diabetic Neuropathy, Spinal Stenosis), by Diagnosis (Imaging, Blood Tests), by Treatment (Medication, Multimodal Therapy), by Distribution Channel (Online Pharmacies, Retail Pharmacies & Drug Stores), by End-user (Hospitals, Clinics, Research Organizations), and Region - Forecast to 2023
Market analysis

Neuropathic pain is generally caused by the peripheral nerve disorder. The higher demand for better treatment methods for pain is hopefully expected to augment the growth of the global neuropathic pain market during the forecast period 2018- 2023. Also, factors such as the introduction of the pain management centers along with higher demand for generic drugs for eliminating the higher levels of pain is anticipated to boost the growth of the global neuropathic pain market. The global neuropathic pain market is expected to exhibit a growth rate of 6.06% CAGR during the forecast period 2018- 2023.

Market segmentation

Based on its type, the global neuropathic pain market is bifurcated into entrapment neuropathy, peripheral neuropathy, post traumatic neuropathy, post herpetic neuralgia (PHN), phantom limb pain, and trigeminal neuralgia. On the basis of its indication, the market is divided into diabetic neuropathy, chemotherapy-induced peripheral neuropathy, and spinal stenosis. Based on its diagnosis, the market is segmented into blood tests, imaging, and physical examination. On the basis of its treatment, the market is classified into medication type and multimodal therapy. Major end-users include clinics, hospitals, and research organizations. Lastly, on the basis of its distribution channels, the market is divided into online pharmacies and retail pharmacies & drug stores.

Regional Analysis

Geographically, the global neuropathic pain market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Sanofi S.A. (France), Abbott Laboratories (U.S.), AstraZeneca (U.K.), GlaxoSmithKline plc (U.K.), and Depomed Inc. (U.S.), Eli Lilly and Company (U.S.), Astellas Pharma Inc. (Tokyo), Biogen Inc. (U.S.), Baxter Healthcare Corporation (U.S.), Pfizer, Inc. (U.S.), among others are some of the major players in the global neuropathic pain market. [table_of_contents] =>

1 Executive Summary
2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising prevalence of diabetic neuropathy within the region
4.2.2 Increasing healthcare expenditure
4.3 Restraints
4.3.1 Increasing counterfeit drugs & side effects of therapeutic treatments
4.3.2 Lack of awareness about the neurological condition
4.4 Opportunities
4.4.1 Growing government funding for healthcare
5 Market Factor Analysis
5.1 Porter’s Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intense Rivalry
5.2 Value chain analysis
5.2.1 R&D
5.2.2 Manufacturing
5.2.3 Distribution & Sales
5.2.4 Post-Sales Monitoring
6 Global Neuropathic Pain Market, By Type
6.1 Overview
6.1.1 Peripheral Neuropathy
6.1.2 Entrapment Neuropathy
6.1.3 Phantom Limb Pain
6.1.4 Trigeminal Neuralgia
6.1.5 Post Herpetic Neuralgia (PHN)
6.1.6 Post Traumatic Neuropathy
7 Global Neuropathic Pain Market, By Indication
7.1 Overview
7.2 Diabetic Neuropathy
7.3 Chemotherapy Induced Peripheral Neuropathy
7.4 Spinal Stenosis
8 Global Neuropathic Pain Market, By Diagnosis
8.1 Overview
8.2 Imaging
8.3 Physical Examination
8.4 Blood Tests
9 Global Neuropathic Pain Market, By Treatment
9.1 Overview
9.2 Medication
9.2.1 Medication Type
9.2.1.1 NSAIDs Type
9.2.1.2 Nerve Blocks Type
9.2.1.3 Antidepressant Drugs Type
9.3 Multimodal Therapy
10 Global Neuropathic Pain Market, By Distribution Channel
10.1 Overview
10.2 Retail Pharmacies & Drug Stores
10.3 Online Pharmacies
11 Global Neuropathic Pain Market, By End-User
11.1 Overview
11.2 Hospitals
11.3 Clinics
11.4 Research Organizations
12 Global Neuropathic Pain Market, By Region
12.1 Introduction
12.2 Americas
12.2.1 North America
12.2.2 US
12.2.3 Canada
12.2.4 South America
12.3 Europe
12.3.1 Western Europe
12.3.2 Germany
12.3.3 UK
12.3.4 France
12.3.5 Spain
12.3.6 Italy
12.3.7 Rest of Western Europe
12.3.8 Eastern Europe
12.4 Asia Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 Australia
12.4.5 Rest of Asia Pacific
12.5 Middle East & Africa
12.5.1 The Middle East
12.5.1.1 United Arab Emirates
12.5.1.2 Saudi Arabia
12.5.1.3 Oman
12.5.1.4 Kuwait
12.5.1.5 Qatar
12.5.1.6 Egypt
12.5.1.7 Jordan
12.5.1.8 Iran
12.5.1.9 Iraq
12.5.1.10 Lebanon
12.5.2 Africa
12.5.2.1 South Africa
12.5.2.2 Morocco
12.5.2.3 Tunisia
12.5.2.4 Algeria
12.5.3 Rest of Middle East & Africa
13 Company Landscape
13.1 Company Market Share Analysis
13.1.1 Introduction
13.2 Competitive Landscape
13.2.1 Introduction
13.3 Key Developments
14 Company Profile
14.1 Sanofi
14.1.1 Company Overview
14.1.2 Financial Overview
14.1.3 Products Offering
14.1.4 Key Developments
14.1.5 SWOT Analysis
14.1.6 Key Strategy
14.2 Pfizer Inc.
14.2.1 Company Overview
14.2.2 Financial Overview
14.2.3 Products Offering
14.2.4 Key Developments
14.2.5 SWOT Analysis
14.2.6 Key Strategy
14.3 Abbott Laboratories
14.3.1 Company Overview
14.3.2 Financial Overview
14.3.3 Products Offering
14.3.4 Key Developments
14.3.5 SWOT Analysis
14.3.6 Key Strategy
14.4 GlaxoSmithKline Plc (GSK)
14.4.1 Company Overview
14.4.2 Financial Overview
14.4.3 Products Offering
14.4.4 Key Developments
14.4.5 SWOT Analysis
14.4.6 Key Strategy
14.5 Eli Lilly and Company
14.5.1 Company Overview
14.5.2 Financial Overview
14.5.3 Products Offering
14.5.4 Key Developments
14.5.5 SWOT Analysis
14.5.6 Key Strategy
14.6 Johnson & Johnson Services Inc.
14.6.1 Company Overview
14.6.2 Financial Overview
14.6.3 Products Offering
14.6.4 Key Developments
14.6.5 SWOT Analysis
14.6.6 Key Strategy
14.7 Depomed Inc.
14.7.1 Company Overview
14.7.2 Financial Overview
14.7.3 Products Offering
14.7.4 Key Developments
14.7.5 SWOT Analysis
14.7.6 Key Strategy
14.8 AstraZeneca
14.8.1 Company Overview
14.8.2 Financial Overview
14.8.3 Products Offering
14.8.4 Key Developments
14.8.5 SWOT Analysis
14.8.6 Key Strategy
14.9 Astellas Pharma Inc.
14.9.1 Company Overview
14.9.2 Financial Overview
14.9.3 Products Offering
14.9.4 Key Developments
14.9.5 SWOT Analysis
14.9.6 Key Strategy
14.1 Biogen Inc.
14.10.1 Company Overview
14.10.2 Financial Overview
14.10.3 Products Offering
14.10.4 Key Developments
14.10.5 SWOT Analysis
14.10.6 Key Strategy
14.11 Baxter Healthcare Corporation
14.11.1 Company Overview
14.11.2 Financial Overview
14.11.3 Products Offering
14.11.4 Key Developments
14.11.5 SWOT Analysis
14.11.6 Key Strategy
15 Appendix
15.1 Discussion Blue Print [list_of_tables] =>

TABLE 1 MARKET SYNOPSIS
TABLE 2 LIST OF ASSUMPTIONS
TABLE 3 GLOBAL NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 4 GLOBAL NEUROPATHIC PAIN MARKET, FOR PERIPHERAL NEUROPATHY BY REGION 2015-2023 (USD MILLION)
TABLE 5 GLOBAL NEUROPATHIC PAIN MARKET, FOR ENTRAPMENT NEUROPATHY BY REGION 2015-2023 (USD MILLION)
TABLE 6 GLOBAL NEUROPATHIC PAIN MARKET, FOR PHANTOM LIMB PAIN BY REGION 2015-2023 (USD MILLION)
TABLE 7 GLOBAL NEUROPATHIC PAIN MARKET, FOR TRIGEMINAL NEURALGIA BY REGION 2015-2023 (USD MILLION)
TABLE 8 GLOBAL NEUROPATHIC PAIN MARKET, FOR POST HERPETIC NEURALGIA (PHN) BY REGION 2015-2023 (USD MILLION)
TABLE 9 GLOBAL NEUROPATHIC PAIN MARKET, FOR POST TRAUMATIC NEUROPATHY BY REGION 2015-2023 (USD MILLION)
TABLE 10 GLOBAL NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 11 GLOBAL NEUROPATHIC PAIN MARKET, FOR DIABETIC NEUROPATHY BY REGION 2015-2023 (USD MILLION)
TABLE 12 GLOBAL NEUROPATHIC PAIN MARKET, FOR CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY BY REGION 2015-2023 (USD MILLION)
TABLE 13 GLOBAL NEUROPATHIC PAIN MARKET, FOR SPINAL STENOSIS BY REGION 2015-2023 (USD MILLION)
TABLE 14 GLOBAL NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 15 GLOBAL NEUROPATHIC PAIN MARKET, FOR IMAGING BY TYPE 2015-2023 (USD MILLION)
TABLE 16 GLOBAL NEUROPATHIC PAIN MARKET, FOR IMAGING BY REGION 2015-2023 (USD MILLION)
TABLE 17 GLOBAL NEUROPATHIC PAIN MARKET, FOR PHYSICAL EXAMINATION BY REGION 2015-2023 (USD MILLION)
TABLE 18 GLOBAL NEUROPATHIC PAIN MARKET, FOR BLOOD TESTS BY REGION 2015-2023 (USD MILLION)
TABLE 19 GLOBAL NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 20 GLOBAL NEUROPATHIC PAIN MARKET, FOR MEDICATION BY REGION 2015-2023 (USD MILLION)
TABLE 21 GLOBAL NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 22 GLOBAL NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 23 GLOBAL NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 24 GLOBAL NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 25 GLOBAL NEUROPATHIC PAIN MARKET, FOR MULTIMODAL THERAPY BY REGION 2015-2023 (USD MILLION)
TABLE 26 GLOBAL NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 27 GLOBAL NEUROPATHIC PAIN MARKET, FOR RETAIL PHARMACIES & DRUG STORES BY REGION 2015-2023 (USD MILLION)
TABLE 28 GLOBAL NEUROPATHIC PAIN MARKET, FOR ONLINE PHARMACIES BY REGION 2015-2023 (USD MILLION)
TABLE 29 GLOBAL NEUROPATHIC PAIN MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 30 GLOBAL NEUROPATHIC PAIN MARKET, FOR HOSPITALS BY REGION 2015-2023 (USD MILLION)
TABLE 31 GLOBAL NEUROPATHIC PAIN MARKET, FOR CLINICS BY REGION 2015-2023 (USD MILLION)
TABLE 32 GLOBAL NEUROPATHIC PAIN MARKET, FOR RESEARCH ORGANIZATIONS BY REGION 2015-2023 (USD MILLION)
TABLE 33 GLOBAL NEUROPATHIC PAIN MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 34 AMERICAS NEUROPATHIC PAIN MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 35 AMERICAS NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 36 AMERICAS NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 37 AMERICAS NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 38 AMERICAS NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 39 AMERICAS NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 40 AMERICAS NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 41 AMERICAS NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 42 AMERICAS NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 43 AMERICAS NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 44 AMERICAS NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 45 AMERICAS NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 46 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 47 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 48 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 49 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 50 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 51 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 52 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 53 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 54 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 55 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 56 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 57 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 58 US NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 59 US NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 60 US NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 61 US NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 62 US NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 63 US NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 64 US NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 65 US NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 66 US NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 67 US NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 68 US NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 69 CANADA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 70 CANADA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 71 CANADA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 72 CANADA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 73 CANADA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 74 CANADA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 75 CANADA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 76 CANADA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 77 CANADA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 78 CANADA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 79 CANADA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 80 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 81 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 82 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 83 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 84 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 85 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 86 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 87 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 88 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 89 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 90 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 91 EUROPE NEUROPATHIC PAIN MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 92 EUROPE NEUROPATHIC PAIN MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 93 EUROPE NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 94 EUROPE NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 95 EUROPE NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 96 EUROPE NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 97 EUROPE NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 98 EUROPE NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 99 EUROPE NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 100 EUROPE NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 101 EUROPE NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 102 EUROPE NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 103 EUROPE NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 104 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 105 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 106 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 107 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 108 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 109 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 110 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 111 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 112 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 113 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 114 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 115 GERMANY NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 116 GERMANY NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 117 GERMANY NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 118 GERMANY NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 119 GERMANY NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 120 GERMANY NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 121 GERMANY NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 122 GERMANY NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 123 GERMANY NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 124 GERMANY NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 125 GERMANY NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 126 UK NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 127 UK NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 128 UK NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 129 UK NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 130 UK NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 131 UK NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 132 UK NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 133 UK NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 134 UK NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 135 UK NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 136 UK NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 137 FRANCE NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 138 FRANCE NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 139 FRANCE NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 140 FRANCE NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 141 FRANCE NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 142 FRANCE NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 143 FRANCE NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 144 FRANCE NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 145 FRANCE NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 146 FRANCE NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 147 FRANCE NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 148 SPAIN NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 149 SPAIN NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 150 SPAIN NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 151 SPAIN NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 152 SPAIN NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 153 SPAIN NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 154 SPAIN NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 155 SPAIN NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 156 SPAIN NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 157 SPAIN NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 158 SPAIN NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 159 ITALY NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 160 ITALY NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 161 ITALY NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 162 ITALY NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 163 ITALY NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 164 ITALY NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 165 ITALY NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 166 ITALY NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 167 ITALY NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 168 ITALY NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 169 ITALY NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 170 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 171 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 172 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 173 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 174 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 175 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 176 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 177 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 178 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 179 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 180 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 181 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 182 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 183 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 184 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 185 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 186 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 187 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 188 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 189 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 190 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 191 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 192 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 193 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 194 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 195 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 196 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 197 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 198 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 199 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 200 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 201 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 202 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 203 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 204 CHINA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 205 CHINA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 206 CHINA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 207 CHINA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 208 CHINA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 209 CHINA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 210 CHINA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 211 CHINA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 212 CHINA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 213 CHINA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 214 CHINA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 215 JAPAN NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 216 JAPAN NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 217 JAPAN NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 218 JAPAN NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 219 JAPAN NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 220 JAPAN NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 221 JAPAN NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 222 JAPAN NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 223 JAPAN NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 224 JAPAN NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 225 JAPAN NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 226 INDIA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 227 INDIA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 228 INDIA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 229 INDIA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 230 INDIA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 231 INDIA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 232 INDIA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 233 INDIA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 234 INDIA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 235 INDIA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 236 INDIA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 237 AUSTRALIA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 238 AUSTRALIA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 239 AUSTRALIA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 240 AUSTRALIA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 241 AUSTRALIA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 242 AUSTRALIA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 243 AUSTRALIA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 244 AUSTRALIA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 245 AUSTRALIA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 246 AUSTRALIA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 247 AUSTRALIA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 248 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 249 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 250 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 251 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 252 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 253 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 254 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 255 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 256 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 257 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 258 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 259 MIDDLE EAST & AFRICA NEUROPATHIC PAIN MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 260 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 261 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 262 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 263 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 264 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 265 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 266 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 267 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 268 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 269 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 270 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 271 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 272 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 273 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 274 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 275 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 276 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 277 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 278 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 279 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 280 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 281 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 282 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 283 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 284 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 285 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 286 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 287 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 288 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 289 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 290 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 291 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 292 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 293 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 294 OMAN NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 295 OMAN NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 296 OMAN NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 297 OMAN NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 298 OMAN NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 299 OMAN NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 300 OMAN NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 301 OMAN NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 302 OMAN NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 303 OMAN NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 304 OMAN NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 305 KUWAIT NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 306 KUWAIT NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 307 KUWAIT NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 308 KUWAIT NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 309 KUWAIT NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 310 KUWAIT NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 311 KUWAIT NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 312 KUWAIT NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 313 KUWAIT NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 314 KUWAIT NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 315 KUWAIT NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 316 QATAR NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 317 QATAR NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 318 QATAR NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 319 QATAR NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 320 QATAR NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 321 QATAR NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 322 QATAR NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 323 QATAR NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 324 QATAR NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 325 QATAR NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 326 QATAR NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 327 EGYPT NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 328 EGYPT NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 329 EGYPT NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 330 EGYPT NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 331 EGYPT NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 332 EGYPT NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 333 EGYPT NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 334 EGYPT NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 335 EGYPT NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 336 EGYPT NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 337 EGYPT NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 338 JORDAN NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 339 JORDAN NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 340 JORDAN NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 341 JORDAN NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 342 JORDAN NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 343 JORDAN NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 344 JORDAN NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 345 JORDAN NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 346 JORDAN NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 347 JORDAN NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 348 JORDAN NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 349 IRAN NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 350 IRAN NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 351 IRAN NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 352 IRAN NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 353 IRAN NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 354 IRAN NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 355 IRAN NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 356 IRAN NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 357 IRAN NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 358 IRAN NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 359 IRAN NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 360 IRAQ NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 361 IRAQ NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 362 IRAQ NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 363 IRAQ NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 364 IRAQ NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 365 IRAQ NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 366 IRAQ NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 367 IRAQ NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 368 IRAQ NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 369 IRAQ NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 370 IRAQ NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 371 LEBANON NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 372 LEBANON NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 373 LEBANON NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 374 LEBANON NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 375 LEBANON NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 376 LEBANON NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 377 LEBANON NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 378 LEBANON NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 379 LEBANON NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 380 LEBANON NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 381 LEBANON NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 382 AFRICA NEUROPATHIC PAIN MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 383 AFRICA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 384 AFRICA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 385 AFRICA NEUROPATHIC PAIN MARKET, BY [list_of_figures] =>

FIGURE 1 GLOBAL NEUROPATHIC PAIN MARKET: MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS OF MRFR
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 PORTER’S FIVE FORCES ANALYSIS: GLOBAL NEUROPATHIC PAIN MARKET
FIGURE 5 VALUE CHAIN: GLOBAL NEUROPATHIC PAIN MARKET
FIGURE 6 GLOBAL NEUROPATHIC PAIN MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
FIGURE 7 GLOBAL NEUROPATHIC PAIN MARKET, BY INDICATION, 2017 & 2023 (USD MILLION)
FIGURE 8 GLOBAL NEUROPATHIC PAIN MARKET, BY DIAGNOSIS, 2017 & 2023 (USD MILLION)
FIGURE 9 GLOBAL NEUROPATHIC PAIN MARKET, BY TREATMENT, 2017 & 2023 (USD MILLION)
FIGURE 10 GLOBAL NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL, 2017 & 2023 (USD MILLION)
FIGURE 11 GLOBAL NEUROPATHIC PAIN MARKET, BY END-USER, 2017 & 2023 (USD MILLION)
FIGURE 12 GLOBAL NEUROPATHIC PAIN MARKET, BY REGION 2017 & 2023 (USD MILLION)
FIGURE 13 AMERICAS NEUROPATHIC PAIN MARKET, BY REGION COUNTRY 2017 (%)
FIGURE 14 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY COUNTRY 2017 (%)
FIGURE 15 EUROPE NEUROPATHIC PAIN MARKET, BY COUNTRY 2017 (%)
FIGURE 16 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY COUNTRY 2017 (%)
FIGURE 17 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY COUNTRY 2017 (%)
FIGURE 18 MIDDLE EAST & AFRICA NEUROPATHIC PAIN MARKET, BY REGION 2017 & 2023 (USD MILLION)
FIGURE 19 MIDDLE EAST & AFRICA NEUROPATHIC PAIN MARKET, BY COUNTRY, 2017 & 2023 (USD MILLION)
FIGURE 20 AFRICA NEUROPATHIC PAIN MARKET, BY REGION 2015-2023 (USD MILLION)
FIGURE 21 GLOBAL NEUROPATHIC PAIN MARKET, MARKET SHARE ANALYSIS 2017 (%)
FIGURE 22 GLOBAL NEUROPATHIC PAINS MARKET COMPETITIVE LANDSCAPE (%) [sample_page] => [brochure] => [new_price] => PDF-4450-Enterprise Wide Licence-6250-Enterprise Wide Licence--Enterprise Wide Licence--Enterprise Wide Licence--Enterprise Wide Licence--Multi User Licence- )
discount aarkstore
Global Neuropathic Pain Market Research Report, by Type (Peripheral Neuropathy, Entrapment Neuropathy, and Others), by Indication (Diabetic Neuropathy, Spinal Stenosis), by Diagnosis (Imaging, Blood Tests), by Treatment (Medication, Multimodal Therapy), by Distribution Channel (Online Pharmacies, Retail Pharmacies & Drug Stores), by End-user (Hospitals, Clinics, Research Organizations), and Region - Forecast to 2023
Market analysis

Neuropathic pain is generally caused by the peripheral nerve disorder. The higher demand for better treatment methods for pain is hopefully expected to augment the growth of the global neuropathic pain market during the forecast period 2018- 2023. Also, factors such as the introduction of the pain management centers along with higher demand for generic drugs for eliminating the higher levels of pain is anticipated to boost the growth of the global neuropathic pain market. The global neuropathic pain market is expected to exhibit a growth rate of 6.06% CAGR during the forecast period 2018- 2023.

Market segmentation

Based on its type, the global neuropathic pain market is bifurcated into entrapment neuropathy, peripheral neuropathy, post traumatic neuropathy, post herpetic neuralgia (PHN), phantom limb pain, and trigeminal neuralgia. On the basis of its indication, the market is divided into diabetic neuropathy, chemotherapy-induced peripheral neuropathy, and spinal stenosis. Based on its diagnosis, the market is segmented into blood tests, imaging, and physical examination. On the basis of its treatment, the market is classified into medication type and multimodal therapy. Major end-users include clinics, hospitals, and research organizations. Lastly, on the basis of its distribution channels, the market is divided into online pharmacies and retail pharmacies & drug stores.

Regional Analysis

Geographically, the global neuropathic pain market is divided into global regions like Europe, North America, Asia- Pacific, Middle East, LATAM, and Africa.

Major players

Sanofi S.A. (France), Abbott Laboratories (U.S.), AstraZeneca (U.K.), GlaxoSmithKline plc (U.K.), and Depomed Inc. (U.S.), Eli Lilly and Company (U.S.), Astellas Pharma Inc. (Tokyo), Biogen Inc. (U.S.), Baxter Healthcare Corporation (U.S.), Pfizer, Inc. (U.S.), among others are some of the major players in the global neuropathic pain market.


1 Executive Summary
2 Market Introduction
2.1 Scope of Study
2.2 Research Objective
2.3 List of Assumptions
2.4 Market Structure
3 Research Methodology
3.1 Research Process
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
3.5 Forecast Model
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Rising prevalence of diabetic neuropathy within the region
4.2.2 Increasing healthcare expenditure
4.3 Restraints
4.3.1 Increasing counterfeit drugs & side effects of therapeutic treatments
4.3.2 Lack of awareness about the neurological condition
4.4 Opportunities
4.4.1 Growing government funding for healthcare
5 Market Factor Analysis
5.1 Porters Five Forces Model
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intense Rivalry
5.2 Value chain analysis
5.2.1 R&D
5.2.2 Manufacturing
5.2.3 Distribution & Sales
5.2.4 Post-Sales Monitoring
6 Global Neuropathic Pain Market, By Type
6.1 Overview
6.1.1 Peripheral Neuropathy
6.1.2 Entrapment Neuropathy
6.1.3 Phantom Limb Pain
6.1.4 Trigeminal Neuralgia
6.1.5 Post Herpetic Neuralgia (PHN)
6.1.6 Post Traumatic Neuropathy
7 Global Neuropathic Pain Market, By Indication
7.1 Overview
7.2 Diabetic Neuropathy
7.3 Chemotherapy Induced Peripheral Neuropathy
7.4 Spinal Stenosis
8 Global Neuropathic Pain Market, By Diagnosis
8.1 Overview
8.2 Imaging
8.3 Physical Examination
8.4 Blood Tests
9 Global Neuropathic Pain Market, By Treatment
9.1 Overview
9.2 Medication
9.2.1 Medication Type
9.2.1.1 NSAIDs Type
9.2.1.2 Nerve Blocks Type
9.2.1.3 Antidepressant Drugs Type
9.3 Multimodal Therapy
10 Global Neuropathic Pain Market, By Distribution Channel
10.1 Overview
10.2 Retail Pharmacies & Drug Stores
10.3 Online Pharmacies
11 Global Neuropathic Pain Market, By End-User
11.1 Overview
11.2 Hospitals
11.3 Clinics
11.4 Research Organizations
12 Global Neuropathic Pain Market, By Region
12.1 Introduction
12.2 Americas
12.2.1 North America
12.2.2 US
12.2.3 Canada
12.2.4 South America
12.3 Europe
12.3.1 Western Europe
12.3.2 Germany
12.3.3 UK
12.3.4 France
12.3.5 Spain
12.3.6 Italy
12.3.7 Rest of Western Europe
12.3.8 Eastern Europe
12.4 Asia Pacific
12.4.1 China
12.4.2 Japan
12.4.3 India
12.4.4 Australia
12.4.5 Rest of Asia Pacific
12.5 Middle East & Africa
12.5.1 The Middle East
12.5.1.1 United Arab Emirates
12.5.1.2 Saudi Arabia
12.5.1.3 Oman
12.5.1.4 Kuwait
12.5.1.5 Qatar
12.5.1.6 Egypt
12.5.1.7 Jordan
12.5.1.8 Iran
12.5.1.9 Iraq
12.5.1.10 Lebanon
12.5.2 Africa
12.5.2.1 South Africa
12.5.2.2 Morocco
12.5.2.3 Tunisia
12.5.2.4 Algeria
12.5.3 Rest of Middle East & Africa
13 Company Landscape
13.1 Company Market Share Analysis
13.1.1 Introduction
13.2 Competitive Landscape
13.2.1 Introduction
13.3 Key Developments
14 Company Profile
14.1 Sanofi
14.1.1 Company Overview
14.1.2 Financial Overview
14.1.3 Products Offering
14.1.4 Key Developments
14.1.5 SWOT Analysis
14.1.6 Key Strategy
14.2 Pfizer Inc.
14.2.1 Company Overview
14.2.2 Financial Overview
14.2.3 Products Offering
14.2.4 Key Developments
14.2.5 SWOT Analysis
14.2.6 Key Strategy
14.3 Abbott Laboratories
14.3.1 Company Overview
14.3.2 Financial Overview
14.3.3 Products Offering
14.3.4 Key Developments
14.3.5 SWOT Analysis
14.3.6 Key Strategy
14.4 GlaxoSmithKline Plc (GSK)
14.4.1 Company Overview
14.4.2 Financial Overview
14.4.3 Products Offering
14.4.4 Key Developments
14.4.5 SWOT Analysis
14.4.6 Key Strategy
14.5 Eli Lilly and Company
14.5.1 Company Overview
14.5.2 Financial Overview
14.5.3 Products Offering
14.5.4 Key Developments
14.5.5 SWOT Analysis
14.5.6 Key Strategy
14.6 Johnson & Johnson Services Inc.
14.6.1 Company Overview
14.6.2 Financial Overview
14.6.3 Products Offering
14.6.4 Key Developments
14.6.5 SWOT Analysis
14.6.6 Key Strategy
14.7 Depomed Inc.
14.7.1 Company Overview
14.7.2 Financial Overview
14.7.3 Products Offering
14.7.4 Key Developments
14.7.5 SWOT Analysis
14.7.6 Key Strategy
14.8 AstraZeneca
14.8.1 Company Overview
14.8.2 Financial Overview
14.8.3 Products Offering
14.8.4 Key Developments
14.8.5 SWOT Analysis
14.8.6 Key Strategy
14.9 Astellas Pharma Inc.
14.9.1 Company Overview
14.9.2 Financial Overview
14.9.3 Products Offering
14.9.4 Key Developments
14.9.5 SWOT Analysis
14.9.6 Key Strategy
14.1 Biogen Inc.
14.10.1 Company Overview
14.10.2 Financial Overview
14.10.3 Products Offering
14.10.4 Key Developments
14.10.5 SWOT Analysis
14.10.6 Key Strategy
14.11 Baxter Healthcare Corporation
14.11.1 Company Overview
14.11.2 Financial Overview
14.11.3 Products Offering
14.11.4 Key Developments
14.11.5 SWOT Analysis
14.11.6 Key Strategy
15 Appendix
15.1 Discussion Blue Print

List Of Tables



TABLE 1 MARKET SYNOPSIS
TABLE 2 LIST OF ASSUMPTIONS
TABLE 3 GLOBAL NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 4 GLOBAL NEUROPATHIC PAIN MARKET, FOR PERIPHERAL NEUROPATHY BY REGION 2015-2023 (USD MILLION)
TABLE 5 GLOBAL NEUROPATHIC PAIN MARKET, FOR ENTRAPMENT NEUROPATHY BY REGION 2015-2023 (USD MILLION)
TABLE 6 GLOBAL NEUROPATHIC PAIN MARKET, FOR PHANTOM LIMB PAIN BY REGION 2015-2023 (USD MILLION)
TABLE 7 GLOBAL NEUROPATHIC PAIN MARKET, FOR TRIGEMINAL NEURALGIA BY REGION 2015-2023 (USD MILLION)
TABLE 8 GLOBAL NEUROPATHIC PAIN MARKET, FOR POST HERPETIC NEURALGIA (PHN) BY REGION 2015-2023 (USD MILLION)
TABLE 9 GLOBAL NEUROPATHIC PAIN MARKET, FOR POST TRAUMATIC NEUROPATHY BY REGION 2015-2023 (USD MILLION)
TABLE 10 GLOBAL NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 11 GLOBAL NEUROPATHIC PAIN MARKET, FOR DIABETIC NEUROPATHY BY REGION 2015-2023 (USD MILLION)
TABLE 12 GLOBAL NEUROPATHIC PAIN MARKET, FOR CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY BY REGION 2015-2023 (USD MILLION)
TABLE 13 GLOBAL NEUROPATHIC PAIN MARKET, FOR SPINAL STENOSIS BY REGION 2015-2023 (USD MILLION)
TABLE 14 GLOBAL NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 15 GLOBAL NEUROPATHIC PAIN MARKET, FOR IMAGING BY TYPE 2015-2023 (USD MILLION)
TABLE 16 GLOBAL NEUROPATHIC PAIN MARKET, FOR IMAGING BY REGION 2015-2023 (USD MILLION)
TABLE 17 GLOBAL NEUROPATHIC PAIN MARKET, FOR PHYSICAL EXAMINATION BY REGION 2015-2023 (USD MILLION)
TABLE 18 GLOBAL NEUROPATHIC PAIN MARKET, FOR BLOOD TESTS BY REGION 2015-2023 (USD MILLION)
TABLE 19 GLOBAL NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 20 GLOBAL NEUROPATHIC PAIN MARKET, FOR MEDICATION BY REGION 2015-2023 (USD MILLION)
TABLE 21 GLOBAL NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 22 GLOBAL NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 23 GLOBAL NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 24 GLOBAL NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 25 GLOBAL NEUROPATHIC PAIN MARKET, FOR MULTIMODAL THERAPY BY REGION 2015-2023 (USD MILLION)
TABLE 26 GLOBAL NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 27 GLOBAL NEUROPATHIC PAIN MARKET, FOR RETAIL PHARMACIES & DRUG STORES BY REGION 2015-2023 (USD MILLION)
TABLE 28 GLOBAL NEUROPATHIC PAIN MARKET, FOR ONLINE PHARMACIES BY REGION 2015-2023 (USD MILLION)
TABLE 29 GLOBAL NEUROPATHIC PAIN MARKET, BY END-USER 2015-2023 (USD MILLION)
TABLE 30 GLOBAL NEUROPATHIC PAIN MARKET, FOR HOSPITALS BY REGION 2015-2023 (USD MILLION)
TABLE 31 GLOBAL NEUROPATHIC PAIN MARKET, FOR CLINICS BY REGION 2015-2023 (USD MILLION)
TABLE 32 GLOBAL NEUROPATHIC PAIN MARKET, FOR RESEARCH ORGANIZATIONS BY REGION 2015-2023 (USD MILLION)
TABLE 33 GLOBAL NEUROPATHIC PAIN MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 34 AMERICAS NEUROPATHIC PAIN MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 35 AMERICAS NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 36 AMERICAS NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 37 AMERICAS NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 38 AMERICAS NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 39 AMERICAS NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 40 AMERICAS NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 41 AMERICAS NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 42 AMERICAS NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 43 AMERICAS NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 44 AMERICAS NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 45 AMERICAS NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 46 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 47 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 48 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 49 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 50 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 51 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 52 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 53 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 54 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 55 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 56 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 57 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 58 US NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 59 US NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 60 US NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 61 US NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 62 US NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 63 US NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 64 US NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 65 US NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 66 US NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 67 US NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 68 US NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 69 CANADA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 70 CANADA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 71 CANADA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 72 CANADA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 73 CANADA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 74 CANADA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 75 CANADA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 76 CANADA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 77 CANADA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 78 CANADA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 79 CANADA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 80 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 81 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 82 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 83 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 84 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 85 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 86 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 87 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 88 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 89 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 90 SOUTH AMERICA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 91 EUROPE NEUROPATHIC PAIN MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 92 EUROPE NEUROPATHIC PAIN MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 93 EUROPE NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 94 EUROPE NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 95 EUROPE NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 96 EUROPE NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 97 EUROPE NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 98 EUROPE NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 99 EUROPE NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 100 EUROPE NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 101 EUROPE NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 102 EUROPE NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 103 EUROPE NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 104 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 105 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 106 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 107 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 108 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 109 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 110 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 111 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 112 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 113 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 114 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 115 GERMANY NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 116 GERMANY NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 117 GERMANY NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 118 GERMANY NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 119 GERMANY NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 120 GERMANY NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 121 GERMANY NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 122 GERMANY NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 123 GERMANY NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 124 GERMANY NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 125 GERMANY NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 126 UK NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 127 UK NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 128 UK NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 129 UK NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 130 UK NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 131 UK NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 132 UK NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 133 UK NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 134 UK NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 135 UK NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 136 UK NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 137 FRANCE NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 138 FRANCE NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 139 FRANCE NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 140 FRANCE NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 141 FRANCE NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 142 FRANCE NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 143 FRANCE NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 144 FRANCE NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 145 FRANCE NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 146 FRANCE NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 147 FRANCE NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 148 SPAIN NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 149 SPAIN NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 150 SPAIN NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 151 SPAIN NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 152 SPAIN NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 153 SPAIN NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 154 SPAIN NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 155 SPAIN NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 156 SPAIN NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 157 SPAIN NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 158 SPAIN NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 159 ITALY NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 160 ITALY NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 161 ITALY NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 162 ITALY NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 163 ITALY NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 164 ITALY NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 165 ITALY NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 166 ITALY NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 167 ITALY NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 168 ITALY NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 169 ITALY NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 170 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 171 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 172 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 173 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 174 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 175 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 176 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 177 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 178 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 179 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 180 REST OF WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 181 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 182 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 183 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 184 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 185 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 186 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 187 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 188 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 189 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 190 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 191 EASTERN EUROPE NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 192 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 193 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 194 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 195 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 196 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 197 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 198 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 199 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 200 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 201 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 202 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 203 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 204 CHINA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 205 CHINA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 206 CHINA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 207 CHINA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 208 CHINA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 209 CHINA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 210 CHINA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 211 CHINA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 212 CHINA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 213 CHINA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 214 CHINA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 215 JAPAN NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 216 JAPAN NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 217 JAPAN NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 218 JAPAN NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 219 JAPAN NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 220 JAPAN NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 221 JAPAN NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 222 JAPAN NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 223 JAPAN NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 224 JAPAN NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 225 JAPAN NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 226 INDIA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 227 INDIA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 228 INDIA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 229 INDIA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 230 INDIA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 231 INDIA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 232 INDIA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 233 INDIA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 234 INDIA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 235 INDIA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 236 INDIA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 237 AUSTRALIA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 238 AUSTRALIA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 239 AUSTRALIA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 240 AUSTRALIA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 241 AUSTRALIA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 242 AUSTRALIA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 243 AUSTRALIA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 244 AUSTRALIA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 245 AUSTRALIA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 246 AUSTRALIA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 247 AUSTRALIA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 248 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 249 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 250 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 251 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 252 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 253 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 254 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 255 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 256 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 257 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 258 REST OF ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 259 MIDDLE EAST & AFRICA NEUROPATHIC PAIN MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 260 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY COUNTRY 2015-2023 (USD MILLION)
TABLE 261 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 262 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 263 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 264 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 265 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 266 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 267 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 268 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 269 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 270 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 271 MIDDLE EAST NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 272 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 273 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 274 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 275 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 276 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 277 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 278 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 279 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 280 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 281 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 282 UNITED ARAB EMIRATES NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 283 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 284 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 285 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 286 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 287 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 288 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 289 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 290 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 291 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 292 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 293 SAUDI ARABIA NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 294 OMAN NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 295 OMAN NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 296 OMAN NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 297 OMAN NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 298 OMAN NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 299 OMAN NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 300 OMAN NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 301 OMAN NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 302 OMAN NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 303 OMAN NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 304 OMAN NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 305 KUWAIT NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 306 KUWAIT NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 307 KUWAIT NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 308 KUWAIT NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 309 KUWAIT NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 310 KUWAIT NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 311 KUWAIT NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 312 KUWAIT NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 313 KUWAIT NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 314 KUWAIT NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 315 KUWAIT NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 316 QATAR NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 317 QATAR NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 318 QATAR NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 319 QATAR NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 320 QATAR NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 321 QATAR NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 322 QATAR NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 323 QATAR NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 324 QATAR NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 325 QATAR NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 326 QATAR NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 327 EGYPT NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 328 EGYPT NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 329 EGYPT NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 330 EGYPT NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 331 EGYPT NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 332 EGYPT NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 333 EGYPT NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 334 EGYPT NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 335 EGYPT NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 336 EGYPT NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 337 EGYPT NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 338 JORDAN NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 339 JORDAN NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 340 JORDAN NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 341 JORDAN NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 342 JORDAN NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 343 JORDAN NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 344 JORDAN NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 345 JORDAN NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 346 JORDAN NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 347 JORDAN NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 348 JORDAN NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 349 IRAN NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 350 IRAN NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 351 IRAN NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 352 IRAN NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 353 IRAN NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 354 IRAN NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 355 IRAN NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 356 IRAN NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 357 IRAN NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 358 IRAN NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 359 IRAN NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 360 IRAQ NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 361 IRAQ NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 362 IRAQ NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 363 IRAQ NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 364 IRAQ NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 365 IRAQ NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 366 IRAQ NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 367 IRAQ NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 368 IRAQ NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 369 IRAQ NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 370 IRAQ NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 371 LEBANON NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 372 LEBANON NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 373 LEBANON NEUROPATHIC PAIN MARKET, BY DIAGNOSIS 2015-2023 (USD MILLION)
TABLE 374 LEBANON NEUROPATHIC PAIN MARKET, BY IMAGING TYPE 2015-2023 (USD MILLION)
TABLE 375 LEBANON NEUROPATHIC PAIN MARKET, BY TREATMENT 2015-2023 (USD MILLION)
TABLE 376 LEBANON NEUROPATHIC PAIN MARKET, BY MEDICATION TYPE 2015-2023 (USD MILLION)
TABLE 377 LEBANON NEUROPATHIC PAIN MARKET, BY NSAIDS TYPE 2015-2023 (USD MILLION)
TABLE 378 LEBANON NEUROPATHIC PAIN MARKET, BY ANTIDEPRESSANT DRUGS TYPE 2015-2023 (USD MILLION)
TABLE 379 LEBANON NEUROPATHIC PAIN MARKET, BY NERVE BLOCKS TYPE 2015-2023 (USD MILLION)
TABLE 380 LEBANON NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL 2015-2023 (USD MILLION)
TABLE 381 LEBANON NEUROPATHIC PAIN MARKET, BY END USER 2015-2023 (USD MILLION)
TABLE 382 AFRICA NEUROPATHIC PAIN MARKET, BY REGION 2015-2023 (USD MILLION)
TABLE 383 AFRICA NEUROPATHIC PAIN MARKET, BY TYPE 2015-2023 (USD MILLION)
TABLE 384 AFRICA NEUROPATHIC PAIN MARKET, BY INDICATION 2015-2023 (USD MILLION)
TABLE 385 AFRICA NEUROPATHIC PAIN MARKET, BY

List Of Figures



FIGURE 1 GLOBAL NEUROPATHIC PAIN MARKET: MARKET STRUCTURE
FIGURE 2 RESEARCH PROCESS OF MRFR
FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH
FIGURE 4 PORTERS FIVE FORCES ANALYSIS: GLOBAL NEUROPATHIC PAIN MARKET
FIGURE 5 VALUE CHAIN: GLOBAL NEUROPATHIC PAIN MARKET
FIGURE 6 GLOBAL NEUROPATHIC PAIN MARKET, BY TYPE, 2017 & 2023 (USD MILLION)
FIGURE 7 GLOBAL NEUROPATHIC PAIN MARKET, BY INDICATION, 2017 & 2023 (USD MILLION)
FIGURE 8 GLOBAL NEUROPATHIC PAIN MARKET, BY DIAGNOSIS, 2017 & 2023 (USD MILLION)
FIGURE 9 GLOBAL NEUROPATHIC PAIN MARKET, BY TREATMENT, 2017 & 2023 (USD MILLION)
FIGURE 10 GLOBAL NEUROPATHIC PAIN MARKET, BY DISTRIBUTION CHANNEL, 2017 & 2023 (USD MILLION)
FIGURE 11 GLOBAL NEUROPATHIC PAIN MARKET, BY END-USER, 2017 & 2023 (USD MILLION)
FIGURE 12 GLOBAL NEUROPATHIC PAIN MARKET, BY REGION 2017 & 2023 (USD MILLION)
FIGURE 13 AMERICAS NEUROPATHIC PAIN MARKET, BY REGION COUNTRY 2017 (%)
FIGURE 14 NORTH AMERICA NEUROPATHIC PAIN MARKET, BY COUNTRY 2017 (%)
FIGURE 15 EUROPE NEUROPATHIC PAIN MARKET, BY COUNTRY 2017 (%)
FIGURE 16 WESTERN EUROPE NEUROPATHIC PAIN MARKET, BY COUNTRY 2017 (%)
FIGURE 17 ASIA PACIFIC NEUROPATHIC PAIN MARKET, BY COUNTRY 2017 (%)
FIGURE 18 MIDDLE EAST & AFRICA NEUROPATHIC PAIN MARKET, BY REGION 2017 & 2023 (USD MILLION)
FIGURE 19 MIDDLE EAST & AFRICA NEUROPATHIC PAIN MARKET, BY COUNTRY, 2017 & 2023 (USD MILLION)
FIGURE 20 AFRICA NEUROPATHIC PAIN MARKET, BY REGION 2015-2023 (USD MILLION)
FIGURE 21 GLOBAL NEUROPATHIC PAIN MARKET, MARKET SHARE ANALYSIS 2017 (%)
FIGURE 22 GLOBAL NEUROPATHIC PAINS MARKET COMPETITIVE LANDSCAPE (%)

2020 Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation, Opportunities

This new report is a seven-country strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key trends in the U.S.,

USD 28500 View Report

2020 Global Transfusion Medicine Market for Over 40 Immunohematology and NAT Tests: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers

This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global transfusion diagnostic market during the next five years,

USD 18500 View Report

Neuropathic Pain - Pipeline Review, H2 2019

Neuropathic Pain - Pipeline Review, H2 2019latest Pharmaceutical and Healthcare disease pipeline guide Neuropathic Pain - Pipeline Review, H2 2019, provides an overview of the Neuropathic Pain (Central Nervous System)

USD 2500 View Report

North America Neuropathic Pain Drugs Market Report (2014-2024) - Market Size, Share, Price, Trend and Forecast

Abstract:The North America Neuropathic Pain Drugs market size is $XX million USD in 2018 with XX CAGR from 2014 to 2018, and it is expected to reach $XX million USD

USD 3000 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available